KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bausch Health Companies (BHC) EBITDA Margin: 2009-2024

Historic EBITDA Margin for Bausch Health Companies (BHC) over the last 16 years, with Dec 2024 value amounting to 16.06%.

  • Bausch Health Companies' EBITDA Margin rose 1042.00% to 23.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 18.92%, marking a year-over-year increase of 467.00%. This contributed to the annual value of 16.06% for FY2024, which is 507.00% up from last year.
  • According to the latest figures from FY2024, Bausch Health Companies' EBITDA Margin is 16.06%, which was up 46.06% from 11.00% recorded in FY2023.
  • In the past 5 years, Bausch Health Companies' EBITDA Margin ranged from a high of 16.06% in FY2024 and a low of 5.34% during FY2021.
  • In the last 3 years, Bausch Health Companies' EBITDA Margin had a median value of 11.00% in 2023 and averaged 10.88%.
  • Its EBITDA Margin has fluctuated over the past 5 years, first soared by 1,078bps in 2020, then tumbled by 309bps in 2021.
  • Over the past 5 years, Bausch Health Companies' EBITDA Margin (Yearly) stood at 8.42% in 2020, then tumbled by 309bps to 5.34% in 2021, then increased by 25bps to 5.59% in 2022, then spiked by 541bps to 11.00% in 2023, then surged by 507bps to 16.06% in 2024.